NCT01349010

Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia

A Randomized, Double Blind, Placebo Control, Multi-center Clinical Study to Evaluate the Efficacy and Safety of Imported Probucol in Hyperlipidemia Patients

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 264 (actual)
• Sponsor: Otsuka Beijing Research Institute · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of imported Probucol in hyperlipidemia patients.

Detailed description

This is a randomized, double blind, placebo control, multi-centre clinical study in hyperlipidemia patients. Enrolled subjects will be randomized to the treatment group or control group, and receive Probucol or placebo continuously for 8 weeks; Treatment group: Imported Probucol 250 mg (1 tablet) bid. p.o Control group: Placebo 1 tablet bid. p.o

Conditions

• Hyperlipidemia

Interventions

Type	Name	Description
DRUG	Probucol	250mg (1 tablet) bid. p.o for 8 weeks
DRUG	Placebo	1 tablet bid. p.o for 8 weeks

Timeline

• Start date: 2011-04-01
• Primary completion: 2012-07-01
• Completion: 2013-02-01
• First posted: 2011-05-06
• Last updated: 2013-06-05

Locations

1 site across 1 country: China